Mercer, Witt/Kieffer and Hunton & Williams sponsored a survey of severance packages for chief executive officers of health care organizations. (Severance Survey) About 200 health care provider and health plan companies were included in the survey, with 90% being providers of one type or another. The respondents reflect a variety of revenue sizes, from less than $100 million to over $2 billion. Over 80% of the organizations had a written severance agreement with the CEO. These are rationalized as necessary to attract and retain good talent and to ensure management transitions. The median severance period is 24 months and most of the CEOs also receive health and other benefits during the severance period. Only one-third reduced the severance by the amounts of other earnings that the CEO might make during the severance period and only two-thirds subjected receipt of severance to a non-compete. Most are triggered by involuntary termination of employment. Even when the firing is highly justified, organizations rarely fight the right to severance, meaning that incompetence and even misbehavior is rewarded. Since many of these organizations, if not the vast majority, are non-profits, it is unclear how giving rich severance packages to already overpaid CEOs is consistent with the mission of serving the communities in which the organizations are located.
Health Care Executive Severance Packages
By Kevin RocheOctober 21, 2013Commentary
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Another example of over-priced companies trying to find some way to survive in the post-epidemic financial world. Transcarent, which does something, somehow to “access high quality, affordable care” is buying...
March 6, 2023
In an attempt to swiftly revive two floundering health care companies, a PE firm has announced the merger and recapitalization of Revive Health and SwiftMD. You know they are...
January 30, 2023
Investors have not yet learned their lesson, as Pearl Health gathers a new round of $75 million in capital for its business of supporting physicians who want to participate in...
January 30, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace
March 21, 2023
Minnesota’s New Energy Insanity, Part 7
Minnesota is a particularly poor place to rely on solar power, but other states aren't…
March 21, 2023
A Quick SVB Follow-up
As I suspected, the SVB saga is primarily one of regulatory malfeasance, coupled with political…
March 19, 2023
Tom Frieden Speaks in the WSJ
A public health expert writes an article for the WSJ which amply demonstrates why Americans…